BridgeBio Pharma, Inc. Marketable Securities, Current in USD from Q3 2019 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
BridgeBio Pharma, Inc. quarterly Marketable Securities, Current history and growth rate from Q3 2019 to Q2 2025.
  • BridgeBio Pharma, Inc. Marketable Securities, Current for the quarter ending June 30, 2025 was $7.94M, a 80.1% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)

BridgeBio Pharma, Inc. Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 $7.94M -$31.9M -80.1% Jun 30, 2025 10-Q 2025-08-05
Q4 2024 $0 $0 Dec 31, 2024 10-Q 2025-08-05
Q2 2024 $39.8M +$8.94M +29% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $44.5M +$10.3M +30.3% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $0 -$51.6M -100% Dec 31, 2023 10-Q 2024-08-01
Q3 2023 $0 -$75.1M -100% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $30.9M -$188M -85.9% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $34.1M -$228M -87% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $51.6M -$342M -86.9% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $75.1M -$344M -82.1% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $218M -$241M -52.4% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $262M -$186M -41.5% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $394M +$143M +56.9% Dec 31, 2021 10-K 2023-02-23
Q3 2021 $419M +$75.6M +22% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $459M +$159M +53.1% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $448M +$300M +202% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $251M +$68.8M +37.8% Dec 31, 2020 10-K 2022-02-25
Q3 2020 $344M +$222M +182% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $300M Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $148M Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $182M Dec 31, 2019 10-K 2021-02-25
Q3 2019 $122M Sep 30, 2019 10-Q 2019-11-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.